| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesia, San Ignacio Hospital, Javeriana University School of Medicine, Bogota, Colombia; and
Departments of Anesthesia and Medicine, Tufts University School of Medicine and Tufts-New England Medical Center, Boston, Massachusetts
Address correspondence to Daniel B. Carr, MD, Department of Anesthesia, Tufts-New England Medical Center, #298, 750 Washington St., Boston, MA 02111. Address e-mail to daniel.carr{at}tufts.edu Reprints will not be available from the author.
| Abstract |
|---|
|
|
|---|
5 on the 010 numeric rating scale (NRS). We administered 2.5 mg of morphine IV every 10 min until the pain intensity was
4 of 10. Every 10 min, patients rated their pain on the NRS and indicated the degree of pain relief on a 5-point Likert scale. After adjustment for type of operation and age, we found that women had more intense pain and had larger morphine consumption than men. The difference in NRS pain intensity was 0.4 U (95% confidence interval, 0.10.6 U). Women required 0.03 mg/kg more morphine than men (95% confidence interval, 0.020.04 mg/kg). We conclude that women have more intense pain and require 30% more morphine to achieve a similar degree of analgesia compared with men. Clinicians should anticipate the differences in opioid requirement to avoid undertreatment of pain in women. IMPLICATIONS: The effect of sex on opioid response is not clear. To determine the effect of sex on morphine consumption and morphine analgesia, we designed a cohort study. We found that women had more intense pain and required 30% more morphine to achieve a similar degree of analgesia compared with men.
| Introduction |
|---|
|
|
|---|
Sex differences are not limited to pain perception but may extend to the response to analgesics. In animals, male rats exhibit greater analgesia than female rats to equal doses of opioids (6,7). In humans, sex differences in response to opioids have been described, but the findings are difficult to consolidate. Results range from women having less pain relief than men after surgery (3) to women having more pain relief than men in response to butorphanol or pentazocine, mixed opioid agonist-antagonists (8,9). Such studies have enrolled a small number of subjects (e.g., as few as 10 women). In addition, these studies evaluated opioid agonist-antagonists, which are not used as often as full agonists, such as morphine. Therefore, we sought to determine the effect of sex on pain perception, morphine consumption, and morphine analgesia after surgery.
| Methods |
|---|
|
|
|---|
65 yr) until their pain intensity was
4 of 10. After incremental doses of morphine were successfully titrated to achieve an NRS pain intensity of
4, subsequent analgesic care was taken over by each patients physician. This is the standard of care in the hospital.
We also recorded demographic characteristics, site of operation (head and neck, thoracic, abdominal, orthopedic, or spinal), the ASA physical status (10), and the intraoperative dose of opioid given. A morphine requirement was equated with the total dose of morphine a patient required to achieve a pain intensity of
4 of 10.
To determine whether there was a difference in opioid requirement between men and women, we used a robust linear regression. Robust regression does not assume normality and minimizes the effect of influential observations; it produces valid and more efficient estimates than the traditional linear regression (11). It weighs less heavily observations that have larger residuals and/or observations that are very influential (i.e., Cooks D values >1) (12). Because the total and weight-adjusted doses of morphine had outliers, in this case robust regression provides a robust estimate that is not distorted by any particular observation. The dependent variable in the regression model was the dose of morphine (mg/kg), and the independent variables were sex, type of surgery, and age. Type of surgery and age are variables that could affect opioid consumption and pain intensity; therefore, it is important that we compared women and men of similar age who underwent similar surgical procedures to obtain valid results.
To see whether pain intensity differed between sexes at baseline, we used a linear regression and controlled for the effect of type of surgery and age. To determine whether the difference persisted throughout the duration of the study, we again used a linear regression in which pain intensity was the dependent variable and the independent variables were sex, site of operation, and age. Because each patient had multiple evaluations (until the NRS pain intensity was
4 of 10) and these measures were not independent, we used an analysis of repeated measures with generalized estimating equations to take this lack of independence into consideration by adjusting the SE values (13,14).
To measure the effect size of the related sex difference in pain intensity, we computed the standarized mean difference as the mean intensity in women subtracted from the mean intensity in men, divided by the pooled SD (1,15). To determine whether there was a difference in pain relief between sexes, we compared the proportion of women and men who achieved a specific degree of pain relief after morphine, by means of the
2 test.
We used Stata Version 7 SE (Stata Corp., College Station, TX) for all statistical analyses. We estimated and reported 95% confidence intervals (CI). P values <0.05 were considered statistically significant.
We estimated that we needed at least 227 patients of each sex to detect a 15% difference in opioid requirements with 80% power and an
error of 5%, assuming an average requirement in the PACU of 10.75 ± 4.75 mg of morphine. This estimated requirement was based on a study we performed in a similar population (3).
We recruited more patients because the primary aim of this study was to determine the meaning to patients of various decrements in the NRS, and for that purpose more patients were needed. The results of the primary study aim are reported elsewhere (16).
| Results |
|---|
|
|
|---|
|
|
After adjusting for type of surgery and age, women had higher levels of pain intensity throughout the study than men. Women had on average 0.2 U higher pain intensity levels than men (95% CI, 0.030.4 U). To achieve the desired level of analgesia in the PACU, subjects needed 42 ± 20 min. Compared with men, women required a little more time: 4 min (95% CI, 17 min).
After adjusting for type of surgery and age, women had larger consumption of morphine than men to achieve NRS scores of
4. Women required 0.03 mg/kg more morphine than men (95% CI, 0.020.04).
The pain intensity levels at the end of the study were 3.5 ± 0.9 in women and 3.4 ± 0.8 in men. The proportion of women and men in each category of pain relief was similar (P = 0.3) (Fig. 1).
|
| Discussion |
|---|
|
|
|---|
Sex differences in pain perception have been attributed to a different socialization process for men and women that influences bodily experience and the willingness to communicate distress (5). Hormone variations could also in part explain sex differences in pain experience and response to morphine (1). Women in the periovulatory, luteal, and premenstrual phases have lower pain thresholds than women in the follicular phase, a difference that is similar to the differences we observed between women and men (0.3 SD) (1).
We found that women require 30% more morphine on a per-weight basis than men to achieve a similar decrease in pain intensity. We believe that a difference of this magnitude is clinically relevant. However, 1 metaanalysis that included 195 women and 119 men who received ibuprofen for dental pain found no sex differences in response to ibuprofen (18), although it did confirm that women reported higher levels of pain intensity. However, the dose of ibuprofen was fixed, so differences in analgesic requirements were not measured. The best way to quantify the effect of an analgesic is to administer the drug until a desired effect is seen, instead of administering a fixed dose. These methods are called "indirect response models" (19,20) and have been used to study drug pharmacokinetics. In our study, we administered analgesics until a desired response was observed; we believe that this method is more sensitive to detect differences in analgesic requirements. Other studies have found that men require more morphine after surgery than women. One small study (21) enrolled only 54 women and 46 men, and morphine was not administered according to weight. Because patient weight was not controlled in that analysis and because women weigh less, the results are not necessary inconsistent with ours. A recent very large study (22) (n = 2298) in the Chinese population reported that women consumed significantly less morphine by using patient-con-trolled analgesia in the first three postoperative days than did men. It is interesting to note that, in contrast to a large body of literature, the authors found that women reported less pain than men. It is possible that cultural, ethnic, or genetic factors may account for the differing findings in the Chinese study and our study. Hospital San Ignacio treats a mixed population of black, Caucasian, and Native Indian patients, but virtually no Asians.
In rat models, opioids consistently produce greater analgesia in males than in females (6,7). Although our study supports these findings, there are reports indicating that pentazocine, butorphanol, and nalbuphineopioids that activate
receptorsproduce a greater degree of analgesia in women than in men after third-molar extraction (8,23). It is difficult to explain this conflicting evidence. The same clinical research group that reported greater analgesia in women exposed to
agonists found no sex differences in response to morphine (23).
To place our findings into clinical perspective, one may consider a 60-kg woman in severe postoperative pain. To achieve adequate pain relief, she will likely require 46.8 mg of morphine over 24 hours (0.13 mg x 60 kg x six doses per day), whereas a man of the same weight will need 36.0 mg. This is a 10.8-mg difference. We consider this difference clinically important but nonetheless acknowledge that the emphasis one places on this difference is a subjective matter.
If women indeed require more morphine than men, the difference in opioid requirements is not likely to be secondary to pharmacokinetic differences. A small study (n = 10 of each sex) to evaluate morphine pharmacokinetics after an IV bolus of morphine reported that concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide did not differ between men and women. These authors found, as we did, that women experienced less weight-adjusted analgesia after morphine than men (24).
In summary, we found that women exhibit higher pain intensity after surgery and have larger weight-adjusted morphine requirements than men to achieve a similar degree of analgesia. Clinicians should anticipate possible sex differences in opioid requirements to avoid undertreatment of pain in women (25).
| Acknowledgments |
|---|
Department of Anesthesia of San Ignacio Hospital Javeriana University School of Medicine, by Colciencias, and the Saltonstall and Armington Funds for Pain Research.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. R. Loyd, X. Wang, and A. Z. Murphy Sex Differences in {micro}-Opioid Receptor Expression in the Rat Midbrain Periaqueductal Gray Are Essential for Eliciting Sex Differences in Morphine Analgesia J. Neurosci., December 24, 2008; 28(52): 14007 - 14017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Chin and R. Rosenquist Sex, Gender, and Pain: "Men Are from Mars, Women Are from Venus ..." Anesth. Analg., July 1, 2008; 107(1): 4 - 5. [Full Text] [PDF] |
||||
![]() |
A. Dahan, B. Kest, A. R. Waxman, and E. Sarton Sex-Specific Responses to Opiates: Animal and Human Studies Anesth. Analg., July 1, 2008; 107(1): 83 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Cepeda, D. B. Carr, T. Sarquis, N. Miranda, R. J. Garcia, and C. Zarate Static Magnetic Therapy Does Not Decrease Pain or Opioid Requirements: A Randomized Double-Blind Trial Anesth. Analg., February 1, 2007; 104(2): 290 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. J. Traub, and A. Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, A. Z. Murphy, and R. J. Traub Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R307 - R314. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Peckham and J. R. Traynor Comparison of the Antinociceptive Response to Morphine and Morphine-Like Compounds in Male and Female Sprague-Dawley Rats J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1195 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mattila, J. Toivonen, L. Janhunen, P. H. Rosenberg, and M. Hynynen Postdischarge Symptoms After Ambulatory Surgery: First-Week Incidence, Intensity, and Risk Factors Anesth. Analg., December 1, 2005; 101(6): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Tosi, B. D. Boyan, and A. L. Boskey Does Sex Matter in Musculoskeletal Health? The Influence of Sex and Gender on Musculoskeletal Health J. Bone Joint Surg. Am., July 1, 2005; 87(7): 1631 - 1647. [Full Text] [PDF] |
||||
![]() |
S.-C. Chen, T.-J. Chang, and F.-S. Wu Competitive Inhibition of the Capsaicin Receptor-Mediated Current by Dehydroepiandrosterone in Rat Dorsal Root Ganglion Neurons J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|